{
  "metadata": {
    "sourceFile": "biotech-ipo-data.csv",
    "processedDate": "2025-06-11T13:28:58.983Z",
    "totalRecords": 168,
    "dataRange": null,
    "columns": ["Company", "Status"],
    "description": "Analysis of 168 biotech companies that completed IPOs and their current status",
    "statusBreakdown": {
      "Listed": 122,
      "Acquired": 23,
      "Reverse Merged": 10,
      "Liquidated": 5,
      "Bankrupt": 4,
      "OTC Trading": 4
    },
    "strategicBreakdown": {
      "Still Independent": 122,
      "Acquired": 23,
      "Distressed": 23
    }
  },
  "companies": [],
  "strategicData": [
    {
      "category": "Still Independent",
      "subcategories": ["Listed"],
      "count": 122,
      "percentage": 72.6,
      "color": "primary",
      "description": "Companies that remain listed and independent",
      "companies": []
    },
    {
      "category": "Acquired",
      "subcategories": ["Acquired"],
      "count": 23,
      "percentage": 13.7,
      "color": "hover",
      "description": "Companies acquired by other firms",
      "companies": []
    },
    {
      "category": "Distressed",
      "subcategories": ["Reverse Merged", "Liquidated", "Bankrupt", "OTC Trading"],
      "count": 23,
      "percentage": 13.7,
      "color": "secondary",
      "description": "Companies experiencing various forms of distress",
      "breakdown": {
        "Reverse Merged": 10,
        "Liquidated": 5,
        "Bankrupt": 4,
        "OTC Trading": 4
      },
      "companies": []
    }
  ]
}
